Rapid COVID-19 vaccine development
Top Cited Papers
Open Access
- 29 May 2020
- journal article
- editorial
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 368 (6494) , 945-946
- https://doi.org/10.1126/science.abb8923
Abstract
Finding the fastest pathway to vaccine availability includes the avoidance of safety pitfallsThis publication has 16 references indexed in Scilit:
- The role of non-viral antigens in the cotton rat model of respiratory syncytial virus vaccine-enhanced diseaseVaccine, 2013
- A Double-Inactivated Severe Acute Respiratory Syndrome Coronavirus Vaccine Provides Incomplete Protection in Mice and Induces Increased Eosinophilic Proinflammatory Pulmonary Response upon ChallengeJournal of Virology, 2011
- Anti-Severe Acute Respiratory Syndrome Coronavirus Spike Antibodies Trigger Infection of Human Immune Cells via a pH- and Cysteine Protease-Independent FcγR PathwayJournal of Virology, 2011
- Antibody-mediated neutralization of flaviviruses: A reductionist viewVirology, 2011
- Atypical Measles and Enhanced Respiratory Syncytial Virus Disease (ERD) Made SimplePediatric Research, 2007
- A role for nonprotective complement-fixing antibodies with low avidity for measles virus in atypical measlesNature Medicine, 2003
- A Role for Immune Complexes in Enhanced Respiratory Syncytial Virus DiseaseThe Journal of Experimental Medicine, 2002
- Summary Report: Workshop on the Potential Risks of Antibody-Dependent Enhancement in Human HIV Vaccine TrialsAIDS Research and Human Retroviruses, 1993
- Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus.The Journal of Immunology, 1993
- Altered Reactivity to Measles VirusJAMA, 1967